share_log

JMP Securities Reiterates Market Outperform on Kura Oncology, Maintains $32 Price Target

Benzinga ·  May 6 11:03

JMP Securities analyst Reni Benjamin reiterates Kura Oncology (NASDAQ:KURA) with a Market Outperform and maintains $32 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment